Medical device licence · 70218 · Class 3
CAPTIA CMV-IGM CAPTURE
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed January 16, 2006; ended October 26, 2021. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 70218
- Licence holder
- Trinity Biotech UsaJamestown, NY, United States
- Risk class
- Class III (moderate to high risk)
- Licence type
- Test Kit
- First licensed
- January 16, 2006
- Ended
- October 26, 2021
- Devices covered
- 1
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- CAPTIA CMV-IGM CAPTURE
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.